Cart
sales@molnova.com
MRT-2359
CAS No. 2803881-11-8
MRT-2359( —— )
Catalog No. M36092 CAS No. 2803881-11-8
MRT-2359 is a potent and orally available GSPT1 reducer with antitumour activity.MRT-2359 inhibits the growth of drug-resistant non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) cells.MRT-2359 exhibits preferential activity in MYC-driven cell lines.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 108 | Get Quote |
|
| 5MG | 164 | Get Quote |
|
| 10MG | 258 | Get Quote |
|
| 25MG | 481 | Get Quote |
|
| 50MG | 686 | Get Quote |
|
| 100MG | 888 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMRT-2359
-
NoteResearch use only, not for human use.
-
Brief DescriptionMRT-2359 is a potent and orally available GSPT1 reducer with antitumour activity.MRT-2359 inhibits the growth of drug-resistant non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) cells.MRT-2359 exhibits preferential activity in MYC-driven cell lines.
-
DescriptionMRT-2359 is an orally active and potent degrader of GSPT1 (IC50: >30 nM and <300 nM) with anti-tumor activity. MRT-2359 also inhibits the growth of resistant non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) cells. MRT-2359 exhibits preferential activity in MYC-driven cell lines, such as N- and L-MYC high NSCLC and SCLC patient-derived xenografts (PDXs).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2803881-11-8
-
Formula Weight495.38
-
Molecular FormulaC22H17F4N3O6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (201.87 mM; Ultrasonic )
-
SMILESO=C1N(CC=2C1=CC(COC(NC3=CC(OC(F)(F)F)=CC=C3F)=O)=CC2)C4C(=O)NC(=O)CC4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Gavory G, et al. Development of MRT-2359, an orally bioavailable GSPT1 molecular glue degrader, for the treatment of lung cancers with MYC-induced translational addiction[J]. Cancer Research, 2023, 83(7_Supplement): 3449-3449.
molnova catalog
related products
-
Chaetocin
Chaetocin, a natural product from Chaetomium species, is a histone methyltransferase inhibitor with IC50 of 0.8 μM, 2.5 μM and 3 μM for dSU(VAR)3-9, mouse G9a and Neurospora crassa DIM5, respectively.
-
PACMA 31
PACMA 31 is an irreversible and covalent inhibitor of protein disulfide isomerase (PDI) with an IC50 of 10 μM. PACMA 31 significantly suppresses ovarian tumor growth and exhibits tumor targeting ability.
-
Palmityl acetate
Palmityl acetate (1-Hexadecanol,1-acetate) is an insect pheromone.
